Tests a structured rehabilitation program for people recovering from ischemic stroke
Tests a new structured rehabilitation program in adults after a first ischemic stroke.
Plain-language title generated from the registry record
Registry title: Stroke Rehabilitation: A Systemized and Hierarchized Rehabilitation Program for the Brazilian Unified Health System
Key facts
- Where
- São Paulo, BrazilSee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults who had one ischemic stroke in the last 24 months and are medically stable. It compares a new rehabilitation program with the usual one.
- Age
- 18 years and older
- Sex
- Women and men can join.
- Disease stage
- One ischemic stroke, confirmed by clinical exam and MRI or CT scan, with onset no longer than 24 months ago, and clinically stable.
Main reasons for not taking part
- Psychiatric disorders
- Bleeding in the brain (subarachnoid or intracerebral hemorrhage)
- Neuromuscular disorders, other neurological diseases or brain tumor
- Cognitive disorders (MoCA score below 20 points)
- High blood pressure (systolic 185 mmHg or higher, or diastolic 110 mmHg or higher)
Read by machine on 9 November 2026.
Where in Brazil
- Instituto de Medicina Física e Reabilitação (IMREA-FMUSP)São Paulo, BrazilNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- University of Sao Paulo
- Trial code
- NCT06494202
- Record updated
- 31 July 2024
- Original description
The goal of this clinical trial is to systemize and hierarchize a rehabilitation program for the Brazilian Unified Health System in patients with stroke above 18 years of age and of both sexes. The main question it aims to answer is:Read full original descriptionShow less
Stroke Rehabilitation: A Systemized and Hierarchized Rehabilitation Program for the Brazilian Unified Health System
The goal of this clinical trial is to systemize and hierarchize a rehabilitation program for the Brazilian Unified Health System in patients with stroke above 18 years of age and of both sexes. The main question it aims to answer is:
* Do patients with ischemic first episode of stroke have central nervous systems consequences due to peripheral and central nervous system sensibilization? * Can stroke patients benefit from a systemized and hierarchized rehabilitation program with desensibilization interventions combined with multidisciplinary and educational programs?
We will randomize 60 patients, 30 in each study arm.
Researchers will compare the intervention group with an active control whose treatment is the institutional conventional program to see if innovative desensibilization strategies yield superior results. Authors will also investigate the role of genetic polymorphism and ancestrality in the outcome measures.
Participants will undertake an innovative or conventional rehabilitation program, according to the randomization.
Inclusion: Clinical and radiological (magnetic resonance or tomography) diagnosis of ischemic stroke; Single episode of stroke; Clinical stability according to medical assessment; Time since stroke onset no longer than 24 months; Capacity to understand the study procedures; Eligible to be admitted to hospitalization at the institute where the study will be conducted; Agree to sign the Informed Consent Form (ICF).
Exclusion: Presence of psychiatric disorders; Presence of subarachnoid hemorrhage; Presence of intracerebral hemorrhage; Presence of neuromuscular disorders; Presence of other neurological diseases or brain neoplasm; Presence of cognitive disorders measured with Montreal Cognitive Assessment (MoCA), scores below 20 points; Presence of systemic arterial hypertension (systolic blood pressure ≥ 185mmHg or diastolic blood pressure ≥ 110 mmHg).